Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
TheraTech, Inc. Patents
Assignee:
TheraTech, Inc.
Address:
Salt Lake City, UT
No. of patents:
36
Patents:












Patent Number Title Of Patent Date Issued
5985317 Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical a November 16, 1999
A method of transdermally or transmucosally delivering a hydrophilic salt form of a drug with a water-based pressure sensitive hydrophobic adhesive matrix patch optionally containing a permeation enhancer is disclosed. A matrix patch comprising a water-based pressure sensitive hydrophobi
5952000 Fatty acid esters of lactic acid salts as permeation enhancers September 14, 1999
A transdermal drug delivery system which enhances the delivery of the drug comprises a composition containing, as an enhancer, one or more C.sub.6 to C.sub.22 fatty acid esters of a lactic acid salt. These compositions are made up of a safe and effective amount of an active pharmaceutica
5912009 Fatty acid esters of glycolic acid and its salts June 15, 1999
A transdermal drug delivery system which enhances the delivery of the drug comprises a composition containing, as an enhancer, one or more C.sub.6 to C.sub.22 fatty acid esters of glycolic acid and its salts. These compositions are made up of a safe and effective amount of an active
5863555 Buccal delivery of glucagon-like insulinotropic peptides January 26, 1999
Drug delivery systems and methods for administering a glucagon-like insulinotropic peptide to the buccal mucosa for transmucosal drug delivery are described. The drug delivery systems comprise a drug composition containing an effective amount of the glucagon-like insulinotropic peptide
5849322 Compositions and methods for buccal delivery of pharmaceutical agents December 15, 1998
A composition for transmucosally administering a drug to the oral cavity comprises an adhesive layer comprising a hydrophilic polymer having one surface adapted to contact a first tissue of the oral cavity and adhere thereto when wet and an opposing surface in contact with and adhering t
5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug November 10, 1998
A composition and method for enhancing transdermal penetration of a basic drug are described. The composition comprises a matrix patch comprising an effective amount of a basic drug, preferably having a pK.sub.a of about 8.0 or greater, an effective amount of a penetration enhancer consi
5783208 Transdermal drug delivery matrix for coadministering estradiol and another steroid July 21, 1998
A matrix type transdermal patch for coadministering estradiol and another steroid wherein the matrix is composed of a N-vinyl-2-pyrrolidone-containing acrylic copolymer pressure sensitive adhesive, estradiol, the other steroid, and optionally a permeation enhancer, and the respective
5780050 Drug delivery compositions for improved stability of steroids July 14, 1998
A stabilized patch device for transdermal drug delivery of steroid drugs containing a 3-keto-4-en functional group is described, wherein the patch comprises an effective amount of the steroid drug and a carrier that is free of acid functional groups. The device can further contain additi
5766620 Buccal delivery of glucagon-like insulinotropic peptides June 16, 1998
Drug delivery systems and methods for administering a glucagon-like insulinotropic peptide to the buccal mucosa for transmucosal drug delivery are described. The drug delivery systems comprise a drug composition containing an effective amount of the glucagon-like insulinotropic peptide
5762953 Transdermal propentofylline compositions for the treatment of Alzheimers disease June 9, 1998
Patients suffering from Alzheimer's disease are treated by transdermally administering an effective amount of propentofylline in the form of an occulsive device containing a delivery composition comprising a carrier vehicle having uniformly distributed therein effective amounts of pr
5686094 Controlled release formulations for the treatment of xerostomia November 11, 1997
A polymeric delivery system which is formed by a polycarbophil type composition with an active agent, optionally in the presence of water and/or other cosolvent. The resulting product is especially useful as a carrier or coating of active compositions, such as pharmaceuticals and the
5662925 Transdermal delivery system with adhesive overlay and peel seal disc September 2, 1997
A device for administering an active agent to the skin or mucosa of an individual comprising a laminated composite of an adhesive overlay, a backing layer underlying the central portion of the adhesive overlay, an active agent-permeable membrane, the backing layer and membrane defining a
5626866 Drug-containing adhesive composite transdermal delivery device May 6, 1997
A method for making a transdermal drug delivery device for heat sensitive and volatile drugs is disclosed. The device contains a drug-containing adhesive composite layer having an impermeable backing material laminated to the distal surface thereof and a proximal peelable impermeable bac
5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug February 11, 1997
A composition and method for enhancing transdermal penetration of a basic drug are described. The composition comprises a matrix patch comprising an effective amount of a basic drug, preferably having a pK.sub.a of about 8.0 or greater, an effective amount of penetration enhancer consist
5585464 Recombinant antigen for diagnosing rheumatoid arthritis December 17, 1996
A method is described for diagnosing rheumatoid arthritis by providing a recombinant antigen (RAMA) and detecting rheumatoid arthritis-associated IgM antibodies against the RAMA antigen in patient sera. The RAMA antigen comprises SEQ ID NO:3 and peptides substantially homologous thereto.
5516523 Transmucosal delivery of macromolecular drugs May 14, 1996
A method and system for mucosally administering a macromolecular drug to mucosa of the oral cavity is shown. The system comprises an inner drug/enhancer/polymer layer having one surface adapted to contact and adhere to the mucosal tissue of the oral cavity and an opposing surface in
5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women October 24, 1995
A method of providing testosterone replacement therapy to a woman in need of such therapy comprising applying a testosterone-delivering patch to the skin of said woman which patch transdermally delivers 50 to 500 .mu.g/day of testosterone to the woman.
5445607 Iontophoresis device and method using a rate-controlling electrically sensitive membrane August 29, 1995
An iontophoresis device comprising a drug reservoir containing the drug in ionic form and in communication with the skin, a skin permeation enhancing agent contained in the reservoir or in a second reservoir also in communication with the skin, an electrode in contact with the drug,
5395753 Method for diagnosing rheumatoid arthritis March 7, 1995
A method is described for diagnosing rheumatoid arthritis by providing a recombinant IgM-specific rheumatoid arthritis-associated antigen and detecting antibodies against the antigen in patient sera. Preliminary steps of making a cDNA library from polyadenylated RNA purified from human
5346701 Transmucosal delivery of macromolecular drugs September 13, 1994
A method and system for mucosally administering a macromolecular drug to mucosa of the oral cavity is shown. The system comprises an inner drug/enhancer/polymer layer having one surface adapted to contact and adhere to the mucosal tissue of the oral cavity and an opposing surface in
5336486 Appetite control method August 9, 1994
A method for suppressing appetite comprising administering by mouth to a subject an amount of polycarbophil that is effective to suppress the appetite of the subject without inducing a laxative effect in said subject.
5302395 Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes April 12, 1994
Transdermal delivery systems for delivery of nitroglycerin are disclosed which deliver the drug at enhanced transdermal fluxes. The systems include, in addition to nitroglycerin, a permeation enhancer which is either a sorbitan ester, a C.sub.8 -C.sub.22 aliphatic alcohol, or a mixtu
5227169 Sorbitan esters as skin permeation enhancers July 13, 1993
Skin permeation enhancer compositions are provided which increase the permeability of skin to transdermally administered pharmacologically active agents. The compositions contain a sorbitan ester in addition to the selected pharmacologically active agent, and may also contain a C.sub
5212199 Sorbitan esters as skin permeation enhancers May 18, 1993
Skin permeation enhancer compositions are provided which increase the permeability of skin to transdermally administered pharmacologically active agents. The compositions contain a sorbitan ester in addition to the selected pharmacologically active agent, and may also contain a C.sub
5202125 Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes April 13, 1993
Transdermal delivery systems for delivery of nitroglycerin are disclosed which deliver the drug at enhanced transdermal fluxes. The systems include, in addition to nitroglycerin, a permeation enhancer which is either a sorbitan ester, a C.sub.8 -C.sub.22 aliphatic alcohol, or a mixtu
5164190 Subsaturated transdermal drug delivery device exhibiting enhanced drug flux November 17, 1992
Transdermal administration of hydrophobic drugs via a diffusion mechanism in which the drug is dissolved in a carrier at concentrations that are 20% to 80% of the saturation concentration. The flux of drug from the device is non-Fickian and is substantially greater than the flux observed
5152997 Method and device for transdermally administering testosterone across nonscrotal skin at therape October 6, 1992
Testosterone is administered transdermally through nonscrotal skin in a manner that mimics in amount and profile the natural production of testosterone in young adult healthy males. The testosterone is administered to the skin from a matrix which contains testosterone at subsaturatio
5139023 Apparatus and method for noninvasive blood glucose monitoring August 18, 1992
The present invention is directed to novel methods and apparatus for noninvasive blood glucose monitoring. Blood glucose is monitored noninvasively by correlation with amount of glucose which permeates an epithelial membrane, such as skin or a mucosal membrane, into a glucose receivi
5122383 Sorbitan esters as skin permeation enhancers June 16, 1992
Skin permeation enhancer compositions are provided which increase the permeability of skin to transdermally administered pharmacologically active agents. The compositions contain a sorbitan ester in addition to the selected pharmacologically active agent, and may also contain a C.sub
5041292 Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents August 20, 1991
A biodegradable hydrogel matrix is provided, useful for the controlled release of pharmacologically active agents. The matrix is formed by cross-linking a proteinaceous component and a polysaccharide or mucopolysaccharide, and then loading a selected drug therein. By varying temperat
4983395 Device for administering an active agent to the skin or mucosa January 8, 1991
A transdermal drug delivery device comprising a drug formulation-containing reservoir defined by a backing layer and a drug-permeable membrane layer, a peelable inner liner that underlies the reservoir and a portion of the backing/membrane outwardly of the reservoir periphery, an adhesiv
4925677 Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents May 15, 1990
A biodegradable hydrogen matrix is provided, useful for the controlled release of pharmacologically active agents. The matrix is formed by cross-linking a proteinaceous component and a polysaccharide or mucopolysaccharide, and then loading a selected drug therein. By varying temperat
4888354 Skin penetration enhancement using free base and acid addition salt combinations of active agent December 19, 1989
The invention is directed to compositions for topical application made up of active pharmaceutical permeants capable of existing in both free base and acid addition salt form. The permeants are present as a combination of both free base and acid addition salt forms. These combined forms
4863970 Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower a September 5, 1989
Penetration-enhancing pharmaceutical compositions for topical transepidermal and percutaneous application are disclosed which are non-irritating to the skin. These compositions are made up of a safe and effective amount of an active pharmaceutical permeant, including hydrophilic salt
4855294 Method for reducing skin irritation associated with drug/penetration enhancer compositions August 8, 1989
A composition and method for reducing the skin irritation properties of a transdermal drug/enhancer composition which comprises incorporating into said composition, either prior to or at the time of application the skin, an effective amount of glycerin. When incorporated into the drug/en
4849224 Device for administering an active agent to the skin or mucosa July 18, 1989
A transdermal drug delivery device comprising a drug formulation-containing reservoir defined by a backing layer and a drug-permeable membrane layer, a ring-shaped layer made of an adhesive that is incompatible with one or more components of the drug formulation that is peripheral to the

 
 
  Recently Added Patents
White polyester film and surface light source therewith
Methods and apparatus for processing audio signals
Electromagnetic shield for a passive electronic component in an active medical device implantable lead
Method for assembling a camera module, and camera module
Interlock apparatus for vacuum circuit breaker
Semiconductor device and fabrication method
State control of remote hosts for management of distributed applications
  Randomly Featured Patents
Chambered enclosure for maintaining a toy in a dry condition
Evacuateable bag
Toy figure and manifold assembly therefor
Injector
Preparation of carboxylates of hydroxyl-containing polymers
Rose plant Jacbor
Portable device including mechanical key
Target gold course and game
Robe hook
Method of forming patterns